CRA economists assisted Xiaomi in its global litigation against Sisvel, involving FRAND rate determination for cellular standard SEPs. CRA provided economic analysis support for Xiaomi in its litigation proceedings in China, Germany, Italy, and Netherlands, and expert reports were submitted in the Netherlands. The parties ultimately settled.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...